Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Join the brightest minds in regulatory at the annual Regulatory Convergence. See the global regulatory community in action. Intensive workshops. Topical sessions. Meet ups with regulators. This is where it all comes together.
For 20 years, our flagship publication, Fundamentals of US Regulatory Affairs, has been giving regulatory professionals the insights and answers they need, right at their fingertips.
There are hundreds of RAC testing centers available worldwide. Any of the four RAC exams (US, EU, CAN or Global) may be taken at any location. Find an upcoming exam at a location near you.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 18 September 2014 | By Louise Zornoza,
This content is provided by RegLink News, publishers of e-weekly global regulatory news. RegLink offers a 30-day free trial and 15% discount on Global Update subscriptions to RAPS members.
Brazilian regulator Anvisa has launched two programs for monitoring the quality of medicines and health products in Brazil.
The National Program for Quality Control of Medicines (Proveme) will initially analyze monthly samples of drugs from Aqui Tem Farmácia Popular and Farmácia Popular, while the Monitoring Project on Health Products Marketed in Brazil will monitor health products available in the market such as orthopedic implants, breast implants and equipment.
The information generated under the two projects will be logged in the SGAWeb system, which is also being launched today. SGAWeb allows labs to record samples received, analysis results and analytical reports issued.
The system was first developed in 2011 by the National Institute of Quality Control in Health (INCQS), in partnership with Anvisa. The goal is for SGAWeb to be used by all of the labs that make up the health surveillance laboratory network, encompassing central, regional, and municipal laboratories, in addition to the provider network.
The agency also launched the Center for Management of Emergency Health Surveillance Information (EVISA). This center is a new unit at Anvisa, which will organize the process of capturing, monitoring and responding to health emergencies. EVISA was inspired by the design of the Global Alert and Response (GAR) public health emergency network, consisting of centers set up in various countries and at the World Health Organization (WHO) in Geneva, and gained momentum with the implementation of International Health Regulation.
(Anvisa)
Tags: Brazil
Regulatory Focus newsletters
All the biggest regulatory news and happenings.